Literature DB >> 7672664

Recurrent Salmonella enteritidis sepsis and hepatic tuberculosis.

M Trauner1, E Grasmug, R E Stauber, H F Hammer, G Hoefler, E C Reisinger.   

Abstract

A 33 year old woman with recurrent Salmonella enteritidis sepsis is described. Penicillins, ceftriaxone, ciprofloxacin, and chloramphenicol could not eradicate the salmonellas but a combination of high dose ciprofloxacin and ceftriaxone for the eighth episode successfully cured the infection. The combination of ciprofloxacin and ceftriaxone may be a valuable therapeutic regimen in patients with recurrent salmonella sepsis. Prolonged intrahepatic cholestasis resulting from granulomatous hepatitis in this patient improved considerably with empiric ursodeoxycholic acid treatment. A liver biopsy specimen showing non-caseating epitheloid granulomas was positive for mycobacterial DNA by polymerase chain reaction. Repeated bronchoscopy with multiple biopsies eventually revealed caseating granulomas with acid fast bacilli in the lung biopsy specimens. Therefore, tuberculosis was diagnosed as the underlying disease and the cause of granulomatous hepatitis in this patient and tuberculostatic treatment was started. Polymerase chain reaction for mycobacterial DNA may be helpful in the differential diagnosis of hepatic granulomas when routine histological examination and culture of biopsy specimens are not diagnostic. Tuberculosis should be considered as one of the diseases predisposing to recurrent salmonella sepsis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7672664      PMCID: PMC1382785          DOI: 10.1136/gut.37.1.136

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  26 in total

1.  Effect of dose size on bioavailability of ciprofloxacin.

Authors:  K I Plaisance; G L Drusano; A Forrest; C I Bustamante; H C Standiford
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

2.  [Anatomo-clinical conference at the Pitié-Salpétrière Hospital. Granulomatous hepatitis in Salmonella typhi septicemia].

Authors:  C Leport; J C Imbert; C Degott
Journal:  Ann Med Interne (Paris)       Date:  1984

3.  Hepatic granulomas: experience over a 10-year period in the West of Scotland.

Authors:  D Cunnigham; P R Mills; E M Quigley; R S Patrick; G Watkinson; J F MacKenzie; R I Russell
Journal:  Q J Med       Date:  1982

4.  Effect of ciprofloxacin on intracellular organisms: in-vitro and in-vivo studies.

Authors:  C S Easmon; J P Crane; A Blowers
Journal:  J Antimicrob Chemother       Date:  1986-11       Impact factor: 5.790

5.  Systemic salmonellosis in patients with disseminated histoplasmosis. Case for 'macrophage blockade' caused by Histoplasma capsulatum.

Authors:  L J Wheat; R H Rubin; N L Harris; E J Smith; R Tewari; S Chaudhary; A Lascari; W Mandell; G Garvey; D Goldberg
Journal:  Arch Intern Med       Date:  1987-03

6.  Histopathological study of protective immunity against murine salmonellosis induced by killed vaccine.

Authors:  I Nakoneczna; H S Hsu
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

7.  Tuberculosis hepatitis: a clinical review of 96 cases.

Authors:  A R Essop; J A Posen; J H Hodkinson; I Segal
Journal:  Q J Med       Date:  1984

8.  Recurrent Salmonella typhimurium bacteremia associated with the acquired immunodeficiency syndrome.

Authors:  J B Glaser; L Morton-Kute; S R Berger; J Weber; F P Siegal; C Lopez; W Robbins; S H Landesman
Journal:  Ann Intern Med       Date:  1985-02       Impact factor: 25.391

9.  Salmonella bacteremia in systemic lupus erythematosus. Eight-year experience at a municipal hospital.

Authors:  S Abramson; S B Kramer; A Radin; R Holzman
Journal:  Arthritis Rheum       Date:  1985-01

10.  Granulomatous hepatitis.

Authors:  P T Harrington; J J Gutiérrez; C H Ramirez-Ronda; R Quiñones-Soto; R H Bermúdez; J Chaffey
Journal:  Rev Infect Dis       Date:  1982 May-Jun
View more
  5 in total

1.  Tuberculosis and the risk of infection with other intracellular bacteria: a population-based study.

Authors:  M A Huaman; C T Fiske; T F Jones; J Warkentin; B E Shepherd; L A Ingram; F Maruri; T R Sterling
Journal:  Epidemiol Infect       Date:  2014-08-22       Impact factor: 2.451

2.  Vacuum-assisted closure therapy of paradoxical reaction in tuberculous lymphadenopathy caused by Mycobacterium africanum.

Authors:  H F Geerdes-Fenge; P Pongratz; J Liese; E C Reisinger
Journal:  Infection       Date:  2018-01-12       Impact factor: 3.553

Review 3.  Examining the Complex Relationship Between Tuberculosis and Other Infectious Diseases in Children.

Authors:  Elizabeth Whittaker; Elisa López-Varela; Claire Broderick; James A Seddon
Journal:  Front Pediatr       Date:  2019-06-25       Impact factor: 3.418

4.  Recurrent paratyphoid fever A co-infected with hepatitis A reactivated chronic hepatitis B.

Authors:  Yanling Liu; Yujiao Xiong; Wenxiang Huang; Bei Jia
Journal:  Ann Clin Microbiol Antimicrob       Date:  2014-05-12       Impact factor: 3.944

5.  Metacarpal tuberculosis with Nocardia infection: A case report.

Authors:  Ruohui Tang; Jing Yang; Huayu Liu; Kai Zhou; Jun Fei
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.